Editorial Methodology
What we verify before listing a provider
Nothing is listed until we can confirm, from the provider's own published information, that:
- Clinicians are licensed by a Canadian provincial College
- A genuine medical assessment is required before any prescription is issued
- Medication is dispensed by a licensed Canadian pharmacy
- The provinces served are stated, and our listing matches them
- Pricing is published, so an all-in cost can actually be calculated
What disqualifies a provider
- Marketing medication to Canadians that is not authorized for sale by Health Canada
- Issuing prescriptions with no clinician review of the intake
- No named licensing jurisdiction for its prescribing clinicians
- Pricing that cannot be determined before payment
How rankings are scored
Position is determined by all-in monthly cost in CAD, breadth of provincial coverage, the clinical model (assessment depth and follow-up cadence), and the pharmacy model. Where two providers are close, we favour the one with wider provincial coverage, because an unavailable provider is worth nothing to the reader it excludes.
We publish an explicit “editorial testing in progress” state rather than filling a category with unverified names. Several categories on this site are in that state today.
Ratings
Ratings reflect our editorial assessment and are assigned by ranked position within a category. They are not aggregated user reviews, and we deliberately do not emit AggregateRating structured data — asserting review counts we did not collect would be a manual-action risk on health content, and it would be dishonest.
Medical claims and sources
Clinical and regulatory claims are cited to Canadian authorities first — Health Canada, Diabetes Canada, Obesity Canada and CMAJ, and Canada's Drug Agency — supplemented by primary clinical literature. We do not cite the FDA for Canadian drug status, because it does not govern it.
Corrections
Provider pricing and coverage change. If something on this site is out of date, tell us on the contact page and we will verify and correct it.
Primary sources we rely on
- Health Canada, Drug Product Database (Health Canada). Whether a specific drug product is authorized for sale in Canada.
- Health Canada, Canada approves first generic semaglutide for weight loss (Health Canada). First generic semaglutide authorized for chronic weight management.
- Obesity Canada and CMAJ, 2025 pharmacotherapy guideline (CMAJ / Obesity Canada). Canadian obesity guideline on long-term weight-management medicine.
- Canada's Drug Agency (CDA-AMC), semaglutide reimbursement review (Canada's Drug Agency). Reimbursement, coverage, and cost-effectiveness review.
- CPSO, Virtual Care policy (College of Physicians and Surgeons of Ontario). What Canadian physicians must do before prescribing virtually.
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.